Wave Life Sciences Ltd. Files 8-K on Director/Officer Changes
Ticker: WVE · Form: 8-K · Filed: Aug 11, 2025 · CIK: 1631574
| Field | Detail |
|---|---|
| Company | Wave Life Sciences Ltd. (WVE) |
| Form Type | 8-K |
| Filed Date | Aug 11, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
TL;DR
Wave Life Sciences filed an 8-K detailing director/officer changes and votes. Expect leadership updates.
AI Summary
Wave Life Sciences Ltd. filed an 8-K on August 11, 2025, reporting events that occurred on August 5, 2025. The filing indicates changes related to directors and officers, the election of directors, appointment of officers, and compensatory arrangements. It also covers the submission of matters to a vote of security holders and includes financial statements and exhibits.
Why It Matters
This filing signals potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in directors and officers, especially if significant, can indicate internal shifts or strategic realignments that may affect the company's future performance.
Key Players & Entities
- Wave Life Sciences Ltd. (company) — Registrant
- August 5, 2025 (date) — Earliest event reported
- August 11, 2025 (date) — Date of report
FAQ
What specific changes were made regarding directors or officers?
The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" as an item of report, suggesting changes in personnel.
Were there any matters submitted to a vote of security holders?
Yes, the filing explicitly lists "Submission of Matters to a Vote of Security Holders" as an item of report.
What is the primary business of Wave Life Sciences Ltd. according to the filing?
The Standard Industrial Classification code provided is 'PHARMACEUTICAL PREPARATIONS [2834]', indicating the company operates in the pharmaceutical sector.
When was the earliest event reported in this 8-K filing?
The earliest event reported occurred on August 5, 2025.
What is the company's jurisdiction of incorporation and fiscal year end?
Wave Life Sciences Ltd. is incorporated in Singapore and its fiscal year ends on December 31.
Filing Stats: 1,167 words · 5 min read · ~4 pages · Grade level 12.5 · Accepted 2025-08-11 17:18:00
Key Financial Figures
- $0 — of each exchange on which registered $0 Par Value Ordinary Shares WVE The N
Filing Documents
- d35789d8k.htm (8-K) — 59KB
- d35789dex101.htm (EX-10.1) — 90KB
- 0001193125-25-178083.txt ( ) — 288KB
- wve-20250805.xsd (EX-101.SCH) — 3KB
- wve-20250805_lab.xml (EX-101.LAB) — 18KB
- wve-20250805_pre.xml (EX-101.PRE) — 11KB
- d35789d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d)Exhibits Exhibit No. Description 10.1+ Wave Life Sciences Ltd. 2021 Equity Incentive Plan, as amended 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) + Indicates management contract or compensatory plan or arrangement.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. WAVE LIFE SCIENCES LTD. By: /s/ Paul B. Bolno, M.D. Paul B. Bolno, M.D. President and Chief Executive Officer Date:August 11, 2025